Provided by Tiger Trade Technology Pte. Ltd.

Neurocrine Biosciences

152.57
-0.3600-0.24%
Pre-market: 153.260.6900+0.45%07:01 EDT
Volume:1.23M
Turnover:188.30M
Market Cap:15.56B
PE:22.36
High:155.27
Open:153.13
Low:152.51
Close:152.93
52wk High:186.12
52wk Low:122.14
Shares:102.00M
Float Shares:100.00M
Volume Ratio:1.11
T/O Rate:1.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):6.82
EPS(LYR):4.67
ROE:22.09%
ROA:11.70%
PB:4.21
PE(LYR):32.67

Loading ...

Neurocrine price target raised to $166 from $151 at Baird

TIPRANKS
·
Apr 07

Neurocrine price target raised to $242 from $204 at Citi

TIPRANKS
·
Apr 07

Neurocrine Biosciences: Vykat XR Acquisition Unlocks Diversified Growth and Upside Potential Despite Near-Term Pipeline Lull

TIPRANKS
·
Apr 07

Neurocrine Biosciences Inc : Canaccord Genuity Raises Target Price to $200 From $164

THOMSON REUTERS
·
Apr 07

Neurocrine Biosciences Inc : Oppenheimer Raises Target Price to $220 From $192

THOMSON REUTERS
·
Apr 07

Dow Jones Top Company Headlines at 7 PM ET: Broadcom to Supply AI Chips to Google, Computing Capacity to Anthropic in Expanded Collaboration | Amazon ...

Dow Jones
·
Apr 07

Analysts Conflicted on These Healthcare Names: Oncolytics Biotech (ONCY) and Neurocrine (NBIX)

TIPRANKS
·
Apr 07

Dow Jones Top Company Headlines at 5 PM ET: Amazon and U.S. Postal Service Reach Delivery Deal | Gulf ...

Dow Jones
·
Apr 07

Oppenheimer Adjusts Neurocrine Biosciences Price Target to $220 From $192, Maintains Outperform Rating

MT Newswires Live
·
Apr 07

US STOCKS-Wall St clings to gains as investors assess US-Iran negotiations, threats

Reuters
·
Apr 07

Top Midday Gainers

MT Newswires Live
·
Apr 07

Neurocrine Price Target Maintained With a $185.00/Share by Needham

Dow Jones
·
Apr 07

These Stocks Are Today's Movers: Seagate, Micron, Kratos, Soleno, Strategy, Paramount, and More -- Barrons.com

Dow Jones
·
Apr 06

Stocks to Watch: Strategy, Tesla, JBS, Paramount -- WSJ

Dow Jones
·
Apr 06

Sector Update: Health Care

MT Newswires Live
·
Apr 06

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Monday Amid Ongoing Iran Conflict

MT Newswires Live
·
Apr 06

Soleno Therapeutics to Be Acquired by Neurocrine Biosciences

TIPRANKS
·
Apr 06

BUZZ-U.S. STOCKS ON THE MOVE-Soleno Therapeutics, Ideaya Biosciences, Profusa

Reuters
·
Apr 06

US STOCKS-S&P 500, Nasdaq futures edge up as investors weigh Mideast developments

Reuters
·
Apr 06